128 related articles for article (PubMed ID: 28089540)
1. Aberrant CDX2 expression in hepatocellular carcinomas: an important diagnostic pitfall.
Shah SS; Wu TT; Torbenson MS; Chandan VS
Hum Pathol; 2017 Jun; 64():13-18. PubMed ID: 28089540
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinomas can be Special AT-rich sequence-binding protein 2 positive: an important diagnostic pitfall.
Lee W; Li X; Chandan VS
Hum Pathol; 2020 Nov; 105():47-52. PubMed ID: 32946879
[TBL] [Abstract][Full Text] [Related]
3. BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas.
Fujikura K; Yamasaki T; Otani K; Kanzawa M; Fukumoto T; Ku Y; Hirose T; Itoh T; Zen Y
Am J Surg Pathol; 2016 May; 40(5):689-96. PubMed ID: 26735860
[TBL] [Abstract][Full Text] [Related]
4. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.
Shahid M; Mubeen A; Tse J; Kakar S; Bateman AC; Borger D; Rivera MN; Ting DT; Deshpande V
Am J Surg Pathol; 2015 Jan; 39(1):25-34. PubMed ID: 25353287
[TBL] [Abstract][Full Text] [Related]
5. SATB2 Is Superior to CDX2 in Distinguishing Signet Ring Cell Carcinoma of the Upper Gastrointestinal Tract and Lower Gastrointestinal Tract.
Ma C; Lowenthal BM; Pai RK
Am J Surg Pathol; 2018 Dec; 42(12):1715-1722. PubMed ID: 30212392
[TBL] [Abstract][Full Text] [Related]
6. Primary liver carcinoma arising in people younger than 30 years.
Klein WM; Molmenti EP; Colombani PM; Grover DS; Schwarz KB; Boitnott J; Torbenson MS
Am J Clin Pathol; 2005 Oct; 124(4):512-8. PubMed ID: 16146811
[TBL] [Abstract][Full Text] [Related]
7. Radiologically Undetected Hepatocellular Carcinoma in Patients Undergoing Liver Transplantation: An Immunohistochemical Correlation With LI-RADS Score.
Xiong W; Cheeney G; Kim S; Kolesnikova V; Henninger B; Alexander J; Swanson PE; Upton MP; Truong CD; Yeh MM
Am J Surg Pathol; 2017 Nov; 41(11):1466-1472. PubMed ID: 28914714
[TBL] [Abstract][Full Text] [Related]
8. EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies.
Cai MY; Tong ZT; Zheng F; Liao YJ; Wang Y; Rao HL; Chen YC; Wu QL; Liu YH; Guan XY; Lin MC; Zeng YX; Kung HF; Xie D
Gut; 2011 Jul; 60(7):967-76. PubMed ID: 21330577
[TBL] [Abstract][Full Text] [Related]
9. A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative.
Clark I; Shah SS; Moreira R; Graham RP; Wu TT; Torbenson MS; Chandan V
Hum Pathol; 2017 Nov; 69():90-95. PubMed ID: 28970136
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of SATB2, CDX2, CDH17 and CK20 in hepatocellular carcinoma: a pathological, clinical and outcome study.
Kmeid M; Lukose G; Hodge K; Cho D; Kim KA; Lee H
Histopathology; 2021 Nov; 79(5):768-778. PubMed ID: 34036629
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics.
Kim H; Park YN
Dig Dis; 2014; 32(6):778-85. PubMed ID: 25376296
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical molecular analysis indicates hepatocellular carcinoma subgroups that reflect tumor aggressiveness.
Tsujikawa H; Masugi Y; Yamazaki K; Itano O; Kitagawa Y; Sakamoto M
Hum Pathol; 2016 Apr; 50():24-33. PubMed ID: 26997435
[TBL] [Abstract][Full Text] [Related]
13. Ki-67 "hot spot" digital analysis is useful in the distinction of hepatic adenomas and well-differentiated hepatocellular carcinomas.
Jones A; Kroneman TN; Blahnik AJ; Graham RP; Mounajjed T; Torbenson MS; Moreira RK
Virchows Arch; 2021 Feb; 478(2):201-207. PubMed ID: 32583014
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens.
Choi WT; Ramachandran R; Kakar S
Hum Pathol; 2017 May; 63():1-13. PubMed ID: 28087475
[TBL] [Abstract][Full Text] [Related]
15. Vascularization of small hepatocellular carcinomas: correlation with differentiation.
Nakashima Y; Nakashima O; Hsia CC; Kojiro M; Tabor E
Liver; 1999 Feb; 19(1):12-8. PubMed ID: 9928760
[TBL] [Abstract][Full Text] [Related]
16. Expression of liver fatty acid binding protein in hepatocellular carcinoma.
Cho SJ; Ferrell LD; Gill RM
Hum Pathol; 2016 Apr; 50():135-9. PubMed ID: 26997447
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma.
Di Tommaso L; Destro A; Fabbris V; Spagnuolo G; Laura Fracanzani A; Fargion S; Maggioni M; Patriarca C; Maria Macchi R; Quagliuolo M; Borzio M; Iavarone M; Sangiovanni A; Colombo M; Roncalli M
Hepatology; 2011 May; 53(5):1549-57. PubMed ID: 21520170
[TBL] [Abstract][Full Text] [Related]
18. Adult-type hepatocellular carcinoma in the center of a fibrolamellar hepatocellular carcinoma.
Seitz G; Zimmermann A; Friess H; Büchler MW
Hum Pathol; 2002 Jul; 33(7):765-9. PubMed ID: 12196930
[TBL] [Abstract][Full Text] [Related]
19. Expression of CDX2 and Thyroid Transcription Factor-1 in Oropharyngeal Undifferentiated Carcinomas: A Potential Diagnostic Pitfall.
Chernock RD; Bibbey S; El-Mofty SK; Carpenter DH; Lewis JS
Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):268-273. PubMed ID: 27389559
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Role of Apelin Receptor Expression in Hepatocellular Carcinoma Treated With Curative Surgical Resection.
Lee T; Park CK; Ha SY
Anticancer Res; 2019 Jun; 39(6):3025-3031. PubMed ID: 31177144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
